Enteral Feeding Devices Market Share, Leading Players and Demand Forecast Report 2032

Market Overview

The global Enteral Feeding Devices Market share is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Releted Reports- 

https://kma.tribe.so/post/enteral-feeding-devices-market-by-business-top-key-players-growth-trend-to---656ed120e8d5e0cbf019b76d

https://buzz.talknewyorkcity.com/post/enteral-feeding-devices-market-size-insights-application-growth-drivers-656ed12282c08eb409897b9d

https://spider-web.mn.co/posts/46538090

https://roggle-delivery.tribe.so/post/enteral-feeding-devices-market-insights-overview-industry-analysis-and-fore--656ed125e5ac2f09de988555

https://healthcaresubmission.blogspot.com/2023/12/enteral-feeding-devices-market-share.html

https://www.click4r.com/posts/g/13314590/

https://followme.tribe.so/post/animal-genetics-market-by-business-top-key-players-growth-trend-to-2032-656ed20a4a5dd7b201556f76

https://yournetwork.tribe.so/post/animal-genetics-market-size-insights-application-growth-drivers-656ed20bbe7fe3f291fbcc57

https://tudomuaban.com/dang-tin-mien-phi.html

https://thankyou.tribe.so/post/animal-genetics-market-insights-overview-industry-analysis-and-forecasts-re--656ed22188381727b028e17e

https://healthcareanna.wordpress.com/2023/12/05/animal-genetics-market-share-leading-players-and-demand-forecast-report-2032/

https://www.social-vape.com/read-blog/92772

Segmentation:

The global enteral feeding devices market outlook has been segmented on the basis of product, age group, indication, end user, and region. 

·       By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·       On the basis of age group, the market has been divided into adults and pediatrics. 

·       By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·       Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market  are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

Medical Device Cleaning Market Share, Size, Trends, Industry Analysis Report to 2032

Medical Device Cleaning Market- Overview

Cleaning medical devices is an essential element of every surgical procedure. Since most medical devices (such as shears, scalpels, retractors, endoscopes, and forceps) are reused in healthcare procedures. Prior to actually being used in subsequent surgical procedures, the medical gadget must be sterilized and cleaned thoroughly to avoid any contamination among patients and the healthcare personnel. Disinfectants and cleansers for cleaning and sanitizing medical devices are found in medical device cleaning. The global Medical Device Cleaning Market Share is predicted to increase at a CAGR of 6.9% from 2023 to 2032.

Due to increased pharmaceutical manufacturing during the pandemic wave, coupled with favorable government initiatives, and the implementation of partial subsidy schemes to slash production costs, pharmaceutical excipients are in high demand.

The global medical device cleaning market dynamics is expected to be driven by stringent rules for reusable medical equipment to aid in reducing the severity of hospital-acquired infections (HAIs), increasing focus on sterilization and disinfection in the healthcare sector, increasing government investments to improve healthcare infrastructure, and increasing healthcare expenditure by patients. UV sanitizing devices are becoming increasingly popular among medical device cleaners. The UV sanitizer effectively kills bacteria on medical instruments and in operating rooms, with minimal contact and increased efficiency as compared to the manual cleaning methods is also estimated to be a key growth segment of the medical device cleaning market share.

Segmental Analysis

The segmentation of the medical device cleaning market outlook is broadly categorized by process, by end users, and by application.

·        On the basis of process, the market segmentation is subdivided into disinfection, automatic cleaning, manual cleaning, and presoak/precleaning. According to various analyses, the segment that is anticipated to have the highest CAGR is automatic cleaning. The primary factor responsible for this upsurge is the increase in demand for smart products and appliances.

·        On the basis of end users, the market is segmented into hospitals, pediatric centers, clinics, diagnostic centers, and dental clinics.

Detailed Regional Analysis

The global medical device cleaning market regions are North America, Europe, and the Asia Pacific. In 2020, North America dominated the market, accounting for about 33.73 percent of worldwide revenue. The increased share acquired by the area is projected to be due to a consistent number of strategic initiatives adopted by leading market players to broaden their brand portfolio and infection control competencies.

By 2028, the Asia-Pacific medical device cleaning market is projected to be valued at USD 8.12 billion. From 2021 to 2028, it is expected to register a CAGR of 11.2%. The development of new technologies for cleansing medical equipment and the increased adoption of preventive measures to limit hospital-acquired infections are the primary factors driving market expansion in the Asia-Pacific (APAC) region. Furthermore, rising concerns about healthcare-associated illnesses spreading through the environment or individuals are a crucial driver driving the APAC market forward. Surgical site infection, for example, is the top infection among overall patients in Asian nations, impacting roughly two-thirds of operated patients, which is nine times higher than in industrialized countries, according to the WHO Patient Safety information page. Furthermore, the Covid-19 pandemic and the high prevalence of infectious diseases are propelling market expansion in this region.

Competitive Analysis

Companies are also pursuing partnerships, mergers, and acquisitions in order to expand their product portfolios, production capabilities and create competitive differences. For instance, a company, PurpleSun Inc., based in the United States, has recently created UV technology that reduced more than 96% of microbes in operating rooms (ORs) and on medical equipment, which is more efficient than manual cleaning methods that rely on chemicals to sanitize surfaces, providing only 38%

The global Medical Device Cleaning Market Players are

         ·         Steris plc,

         ·         GetingeAB,

         ·         Advanced Sterilization Products,

         ·         Biotrol,

         ·         Oro Clean Chemie AG,

         ·         Cantel Medical Corp,

         ·         Sklar Surgical Instruments.

Related reports-

Microsurgery Market Research Report - Global Forecast till 2030

Breast Cancer Market Research Report - Forecast To 2030

Contract Research Organization (CRO) Market Research Report – Forecast till 2030

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

Pacemaker Market Share accelerating a CAGR during the forecast period

Market summery -

Global Pacemaker Market Share is expected grow a CAGR of 3.60% over the forecast period of 2023-2032, as per the latest study report by Market Research Future (MRFR).

Pacemakers regularize heart rhythm by sending electric pulses to the heart and help in restoring cardiac activity. The surge in the prevalence of cardiac diseases has generated high demand for pacemakers which is driving the growth of the global pacemaker market. Atrial fibrillation, in particular, has witnessed a higher incidence rate in recent years which requires pacemakers for remediation. Increase in global geriatric population is also creating a conducive environment for the growth of the market. Atrial fibrillation and cardiac diseases are more prevalent in old patients. As per a 2018 study published in the Aging Medicine, there is 5 to 9% chance of occurrence of atrial fibrillation in patients between the age of 60-80 years and nearly 10% in patients aged over 80 years.

Technological advancements have resulted in the development of advanced pacemakers which are smaller in size and have longer battery life. Other factors aiding the growth of the market include an elevated level of awareness regarding cardiovascular diseases, improvement in reimbursement scenario, and high healthcare expenditure across the globe.

In recent years, various new pacemakers have received clearance from regulatory bodies which also has augmented the growth of the global pacemaker market. However, the approval and marketing if pacemakers are regulated by the US FDA which are stringent considering the degree of risk they pose to patients. Such stringent regulatory requirements might impede the growth of the market. High costs of pacemakers, risks involved in implantation procedures and risks of malfunctioning are other possible bottlenecks.

Segmentation

The global pacemaker market outlook has been segmented based on product type, application, implant approach, and end-user.

By product type, the global pacemaker market has been segmented into implantable and external. The implantable segment has been further segmented into single chamber, dual chamber, and biventricular.

By application, the global pacemaker market has been segmented into bradycardia, heart failure, hypertrophic cardiomyopathy, syncope, and others. The bradycardia segment has been further segmented into sinus node dysfunction and AV block.

By implant approach, the global pacemaker market has been segmented into endocardial approach and epicardial approach.

By end-user, the global pacemaker market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

Competitive Landscape

Global pacemaker market players are below.

ZOLL Medical Corporation, MEDICO S.p.A, Cordis, Inc., St. Jude Medical Inc., Biotronik GmbH & Co. KG, Boston Scientific Corporation, General Electric Company, Pacetronix, Medtronic Plc, Sorin Group, Edwards Lifesciences, Cook, and Vitatron are the key players in the global pacemaker market.

Regional Analysis

By region, the global pacemaker market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas account for the largest share of the global pacemaker market. Presence of a robust healthcare sector and technological advancements accelerate the growth of the market. The FDA has also been approving various novel pacemakers in the region. Moreover, the presence of various medical device manufacturers and surging cases of cardiovascular disorders support market growth in the Americas.

Europe follows the Americas closely and ranks second in the global pacemaker market. Growing government support in the form of R&D grants and the growing presence of key players in the region drive the market in Europe. The growing incidence rate of cardiovascular diseases and high healthcare expenditure are other factors substantiating the growth of the market.

APAC pacemaker market is driven by the growing prevalence of atrial fibrillation in the region. In addition, the region has emerged as a medical tourism hub which is likely to propel the growth of the market. Increasing healthcare expenditure and the presence of a large pool of cardiac patients also will have a positive impact on market growth.

The MEA market is likely to exhibit sluggish growth due to lack of healthcare infrastructure, lack of technical knowledge and less awareness regarding cardiac medical conditions.

Abut US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Health Sensors Market Outlook, Trends, Size and Forecast To 2032

Market Overview

The health sensor market share is projected to grow from USD 48.9 Billion in 2023 to USD 190.3 Billion by 2032, exhibiting a CAGR of 18.50% during the forecast period (2023 - 2032). 

Competitive Analysis

Health Sensors market players, including Analog Devices Inc., Avago Technologies Ltd., Danaher Corp., GE Healthcare, Honeywell International Inc., Medtronic Plc, Smith’s Medical Inc., Koninklijke Philips, Sensirion AG, Stryker Corp., Abbott Laboratories, Roche, Hologic, and Varian Medical System, are attempting to increase market demand by investing in research and development operations.

Regional Analysis

In 2022, 45.80% of the health sensors market was in North America. This is because of the country's advanced healthcare system, large healthcare spending, prevalence of monopolistic enterprises, and rapid adoption of innovative medical technologies. North America is a major player in the global market for health sensors.

In 2022, the health sensor market in Europe was thriving. Growth in the necessity for emergency treatment and the utilization of mobile surgery centers are expected to propel the market throughout the forecast time frame. Not only did Germany dominate the health sensors business, but the United Kingdom's was the most dynamic in Europe.

Between 2023 and 2032, the market for health sensors in Asia and the Pacific is projected to expand at a rapid clip. The rising incidence of cardiovascular disease in Asia and the Pacific has increased demand for health sensor technology in the region. Moreover, China and India are the worst-affected countries because they have the highest diabetes prevalence worldwide.

Market Dynamics

Technology improvements are related to the increase in the prevalence of chronic diseases, the need for constant monitoring, and the tracking of health data. As the global burden of chronic diseases grows, so too will the need for health sensors. The growth of the Health Sensors Market Outlook is being fueled by a number of factors, including technological progress, the increasing prevalence of chronic diseases, the growing need for constant monitoring, and the growing need to keep track of health data.

An advent in people's interest in recording and tracking information about their health habits is expected to boost industry growth, as the personal informatics movement initially gained popularity with the release of mobile apps that made it simpler for people to keep track of miles run, calories consumed per day, among other things.  Health sensors that detect things like body temperature, heart rate, pulse, heat flux, and galvanic skin responses are becoming increasingly available from a variety of companies. That's why there's been a recent uptick in inquiries for health data monitoring.

The personal informatics movement rose to prominence initially due to the proliferation of mobile applications that simplified the process of recording and monitoring health-related data, such as the number of steps taken each day or the number of calories consumed. As more and more devices with built-in accelerometers and sensors have been released, consumers no longer need to manually enter data. 

Market Segmentation

By application, the chronic illness & at risk-monitoring segment accounted for the largest revenue share in 2022. 

By product, the wearable sensors segment dominated the Health Sensors Market in 2022. 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Infectious Disease Diagnosis & Treatment Market Share, Industry Growth Analysis, CAGR Status & Major Key Players

Market Highlights

Infectious diseases includes diseases like tuberculosis, hepatitis and many other diseases caused by viruses, fungi or bacteria. Asia Pacific region has tropical climate and more humidity which is more suitable for the growth of the different microorganisms which can cause different diseases. Increasing prevalence of Infectious diseases such as tuberculosis and AIDS in Asia Pacific region is the major driving factor for the growth of the market. Increasing burden of different infectious diseases has increase the demand for the different diagnostic test and treatment for the different infectious diseases. Infectious Disease Treatment Market Share in APAC Share is expected to grow at a CAGR of 2.9% during forecasted period.

Segmentation:
Asia Pacific infectious disease diagnosis & treatment market outlook is segmented

·        on the basis of application into AIDS, Tuberculosis (TB), Hepatitis, HPV, and others.

·        On the basis treatment it is segmented into Antibiotics, antivirals, antifungals, anti-parasitic, alternative medicine and others.

·        On the basis of diagnostic techniques they are immunoassays, PCR, cell cultures and other 

·        By end user the market is segmented as hospitals, clinics, reference labs and others

Due to increasing prevalence infectious diseases like tuberculosis and AIDS in Asia Pacific region has attracted many companies for the development of the market in Asia Pacific region. Companies are concentrating on the development of new and better diagnostic test and treatment for the different diseases. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Key Players:

The major key player for the Asia Pacific infectious disease diagnosis & treatment market are 

         ·         Abbott Laboratories (US),

         ·         Becton Dickinson & Co. (US),

         ·         Alere, Inc. (US),

         ·         Bio-Rad Laboratories (US),

         ·         Cipla (India), 

         ·         Danaher Corporation (US),

         ·         Glaxosmithkline (UK),

         ·         IPCA Laboratories (India),

         ·         Pfizer (US),

         ·         Roche Diagnostics (Switzerland),

         ·         Johnson And Johnson (US),

         ·         Novartis International (Switzerland),

         ·         Siemens Healthcare (Germany),

         ·         Thermo Fisher Scientific, Inc. (US),

         ·         Vertex Pharmaceuticals (US) and others

Regional Analysis

On regional basis, China commands the largest market for Asia Pacific infectious disease diagnosis & treatment market. Presence of huge population and increasing peoples suffering from TB are the major reason for the development of this market in China. China contribute 10 % of total TB population in the world. India has the second largest market for infectious disease diagnosis & treatment. Presence of highest TB patient in the world is the major driving factor for the market. Continuous development in the healthcare sector and increasing healthcare expenditure is also increased the infectious disease diagnosis & treatment market in India.

Related reports-

Global DPT vaccine Market Research Report- Forecast To 2030

Medical Writing Market Research Report - Forecast till 2030

Dental Consumables Market Research Report- North America Forecast till 2030

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Respiratory Therapeutic Devices Market Overview : A Strategic Analysis of the Key Players and Their Strategies

Market Highlights 

The Respiratory Therapeutic Devices Market Overview is anticipated to reach USD 12,231.6 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030. 

Respiratory therapeutic devices are used in the treatment, management, and control of cardiopulmonary diseases such as chronic obstructive pulmonary diseases (COPD), asthma, acute bronchitis, cystic fibrosis, and others. Increasing prevalence of asthma drives the market along with increasing per capita healthcare expenditure. According to the World Health Organization in 2017, approximately 235 million people have asthma. Moreover, it was estimated that in 2015, the diseases killed approximately 383 million patients around the globe. However, the market growth during the forecast period is likely to hamper due to low per capita income in the developing economies and lack of awareness.

Regional Analysis

The Americas dominate the global respiratory therapeutic devices market insights owing to a huge patient population having cardiopulmonary diseases and well-developed healthcare sector. Moreover, the concentration of the global players like Masimo., BD., Smiths Group plc., besides others along with the increasing healthcare expenditure fuels the regional market growth during the forecast period. In 2015, according to the Centers for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. 

Europe is the second largest respiratory therapeutic devices market owing to a well-developed healthcare infrastructure, government support for research & development, and huge patient population. In 2017, according to a study published in the Asthma Research and Practice Journal, the total estimated cost per year for all the asthmatics per patient is about USD 1,900. 

Asia Pacific is the fastest growing market due to the presence of a huge patient population, continuously developing economies like India and China, and the presence of huge opportunities in the market. Moreover, favorable government policies and increasing healthcare expenditure fuel the market within the region. 

On the other hand, the Middle East & Africa holds the least share of the global respiratory therapeutic devices market due to the presence of poor economy, especially, within the African region. Majority of the market of this region is held by the Middle East due to the huge healthcare expenditure. 

Key Players

Global Respiratory Therapeutic Devices Market Players are

Masimo. (U.S.),

BD. (U.S.),

Smiths Group Plc. (U.S.),

F. Hoffmann-La Roche Ltd (Europe),

Bayer AG (Europe),

Rotech Healthcare Inc. (U.S.),

Chart Industries (U.S.),

Acare Technology (Asia Pacific), and

others.

Segmentation

The global respiratory therapeutic devices market report is segmented on the basis of product, technology, application, and end users.

On the basis of the product, the market is segmented into nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is sub-segmented into soft mist inhaler, human-powered nebulizer, and others. The capnography segment is sub-segmented into main-stream capnography, side-stream capnography, and others.

On the basis of the technology, the market is segmented into electrostatic filtration, HEPA filtration, hollow fiber filtration, microsphere separation, and others.

On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, retail pharmacies, home care, and others. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013              

Dental Bone Graft Substitutes Market Overview Trends, Recent Developments and Technology by 2032

Market Synopsis:

Market Research Future (MRFR)’s latest study reveals that the global Dental Bone Graft Substitutes Market Report is expected to reach at 9.1% CAGR over the estimated 2023-2032. The increasing prevalence of diseases related to bones has intensified the demand for bone graft substitutes. Additionally, the rising awareness about the developments in bone graft substitutes coupled with rising healthcare expenditure is likely to augment the market size and revenue over the next couple of years.

The painful procedure related to autografts have paved the way for developments in the Dental Bone Graft Substitutes Market. Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise. It is projected to aid the proliferation of the market in the forthcoming years by accelerating its adoption.

Regional Insights:

By region, the global dental bone graft substitutes market overview has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounted for the largest share of the global market in 2016. It is expected to retain a significant share of the market by the end of 2027 striking a CAGR of 6.1%. The growth is attributable to the technological advancements in health care, the presence of key players, etc. The developed healthcare sector of the U.S. is poised to be one of the primary revenue generators in the regional bone graft substitutes market.

Europe is the second largest market for bone graft substitutes. It is estimated to thrive at 6.76% CAGR owing to increasing awareness about bone graft substitutes and rising healthcare expenditure. Meanwhile, Asia Pacific is set to register a relatively higher CAGR of 6.85% during the forecast period. The presence of fast-developing economies such as China and India are immensely supporting the growth of the bone graft substitutes market in the region. The trend is likely to perpetuate over the next couple of years.

The Middle East & Africa is expected to exhibit steady growth due to the developments in the healthcare sector in Gulf nations. However, the poor socio-economic situation in African regions remains an impediment to the market growth.

Competitive Dashboard:

Sone of the key Dental Bone Graft Substitutes Market players profiled in the report includes

·        ACE Surgical Supply Company, Inc.,

·        Dentium Co., Ltd.,

·        BioHorizons IPH, Inc.,

·        Dentsply Sirona,

·        Medtronic plc,

·        Stryker Corporation,

·        Zimmer Biomet, and

·        Institut Straumann AG.

Market Segmentation:

·       By type, the global bone graft substitutes market is segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others.

·        By application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.

The growth of the bone graft substitutes market is guided by the factors such as increasing orthopedic problems, exponential geriatric population, and rising demand for reconstructive orthopedic treatments. The adoption of bone graft substitutes in the oral healthcare sector is another factor responsible for catalysing the growth of the bone graft substitutes market through the assessment period.

The dental bone graft membrane market is poised to remain highly lucrative in the foreseeable future. However, risks associated with disease transmission in allografts and xenograft as well as graft rejection, improper fixation, etc. are prognosticated to restrict the market expansion over the forecast period.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013